These findings suggest that serum sTIM-3 upregulation may be associated with autoimmune responses in RA patients with high ACPA titers, whereas serum sTIM-3 was upregulated in response to inflammatory mediators in RA patients with low ACPA titers. Here, PRTN3 is linked to rheumatoid arthritis.